Dolby Laboratories (NYSE:DLB – Get Free Report) issued an update on its second quarter 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 1.190-1.340 for the period, compared to the consensus EPS estimate of 1.350. The company issued revenue guidance of $355.0 million-$385.0 million, compared to the consensus revenue estimate of $387.2 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.
Dolby Laboratories Price Performance
Shares of Dolby Laboratories stock traded down $0.02 on Wednesday, reaching $80.59. 405,447 shares of the company traded hands, compared to its average volume of 450,844. The company has a 50 day moving average of $79.18 and a 200 day moving average of $75.62. Dolby Laboratories has a 52 week low of $66.35 and a 52 week high of $85.30. The firm has a market capitalization of $7.69 billion, a PE ratio of 29.74 and a beta of 0.98.
Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The electronics maker reported $0.84 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.23). Dolby Laboratories had a net margin of 20.56% and a return on equity of 11.19%. As a group, analysts anticipate that Dolby Laboratories will post 2.92 earnings per share for the current year.
Dolby Laboratories Increases Dividend
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on the stock. Rosenblatt Securities reissued a “buy” rating and issued a $100.00 price target on shares of Dolby Laboratories in a research report on Thursday, January 23rd. Barrington Research reissued an “outperform” rating and set a $100.00 price objective on shares of Dolby Laboratories in a report on Monday. Finally, StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a report on Wednesday, December 4th.
Read Our Latest Report on Dolby Laboratories
Insiders Place Their Bets
In other news, EVP Mark Andrew Sherman sold 12,338 shares of Dolby Laboratories stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $78.08, for a total transaction of $963,351.04. Following the completion of the sale, the executive vice president now owns 62,397 shares in the company, valued at approximately $4,871,957.76. This trade represents a 16.51 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Peter C. Gotcher sold 6,079 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $78.96, for a total transaction of $479,997.84. Following the completion of the transaction, the director now owns 37,593 shares in the company, valued at approximately $2,968,343.28. This trade represents a 13.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 135,917 shares of company stock worth $10,877,739 in the last three months. 38.39% of the stock is currently owned by corporate insiders.
About Dolby Laboratories
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Steel Stocks Soaring After Tariff Announcements
- What is a Dividend King?Â
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- How to Read Stock Charts for Beginners
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.